Hence, reduced mTNFα expression on IFN-DCs from glioblastoma patients could be a key factor responsible for the impaired cytotoxic DC function against tumor cells sensitive to TNFα/TNF-R1-dependent lysis. The gene discussed is TNFRSF1A; the disease is glioblastoma.